Device Showcase
Download the app!
INSTALL
Evidence Central
  • Home
  • Favorites
  • Notes
  • Prime PubMed
  • Mobile
  • Browse
Log in
  • REFINE YOUR SEARCH:
  • 20All Results
  • Evidence-Based Medicine GuidelinesEvidence-Based Medicine Guidelines
  • EE+ POEM ArchiveEE+ POEM Archive
  • Cochrane AbstractsCochrane Abstracts
Statins for acute coronary syndrome
20 results
1 - 20
  • EBMG Statins for acute coronary syndrome
    • Evidence Summaries
    • References
  • CochraneStatins for acute coronary syndrome Stable (no update expected for reasons given in 'What's new')
    • Abstract
    • Reviewer's Conclusions
  • EBMG Acute coronary syndrome and myocardial infarction
    • Follow-up management
      • Evidence Summaries
    • Treatment of UA and NSTEMI
      • Evidence Summaries
  • EBMG Coronary heart disease
    • Workup
    • Pharmacotherapy: aims and modes of action
  • CochraneOmega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease New search for studies and content updated (conclusions changed)
    • Reviewer's Conclusions
  • infoPOEMsPSK9 inhibitor alirocumab reduces nonfatal MI in patients after acute coronary syndrome, but at high cost (ODYSSEY OUTCOMES)
    • General
  • EBMG Intensive versus moderate statin therapy
    • Evidence Summaries
  • infoPOEMsBetter medication adherence with intervention; clinical outcomes unchanged
    • General
  • infoPOEMsLipid lowering is beneficial for secondary prevention but not primary prevention in patients 75 years and older
    • General
  • EBMG Routine or selective invasive strategy for acute coronary syndrome
    • Evidence Summaries
  • CochraneEzetimibe for the prevention of cardiovascular disease and all-cause mortality events: Cochrane systematic review
    • Abstract
    • Reviewer's Conclusions
  • infoPOEMsRisk of stroke after TIA is 2.8% at 1 month and 5.1% at 1 year
    • General
  • infoPOEMsOverview of new ACC/AHA lipid guidelines: here we go again
    • General
  • 1 - 20 of 20 records
Renew my subscription

We're glad you have enjoyed Evidence Central! As a thank-you for using our site, here's a discounted rate for renewal or upgrade.

Your free 1 year of online access expired  .

Want to regain access to Evidence Central?

Log in to Evidence Central

Note: Your username may be different from the email address used to register your account.

Contact Support

If you need further assistance, please contact Support.
  • unboundmedicine.com/support
  • support@unboundmedicine.com
  • 610-627-9090(Monday - Friday, 9 AM - 5 PM EST.)
Password reset sent
Username sent
Forgot your username or password?
Purchase Evidence Central
New to Evidence Central?
Purchase a subscription
A Evidence Central subscription is required to
Already have an account?Log In
Purchase Evidence Central
New to Evidence Central?
Purchase a subscription
Unbound Medicine logo
  • Home
  • Contact Us
  • Privacy / Disclaimer
  • Terms of Service
  • Log in

© 2000–2021 Unbound Medicine, Inc. All rights reserved

CONNECT WITH US

facebooktwitteryoutubeinstagram

6.0-2447